Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
FDA Drug recall issued Aug 21, 2026.
AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.
Check the lot code, best-by date, and package size on the agency notice before you throw anything out — most recalls cover only a few production runs, not the whole brand.
Do not open or taste a recalled food to judge it. Contamination like listeria, salmonella, or undeclared allergens has no smell or taste.
Wash anything the product touched — shelves, cutting boards, containers — with hot soapy water, then sanitize.
Keep the receipt or a photo of the label. Nearly every food recall includes a full refund with no receipt required, but a photo speeds it up.
If you or a family member got sick, call your doctor first, then report it to the agency using the link on the notice. Illness reports are how the recall gets widened.
Sourced from FDA and USDA public recall feeds. Notices are federal government works; we summarize dates and link to the official announcement.